CAW
GHDX

Cornerstone Advisors (Washington)’s Genomic Health, Inc. GHDX Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-241
Closed -$14K – 1514
2019
Q2 		$14K Hold
241
– – ﹤0.01% 712
2019
Q1 		$17K Buy
+241
New +$17.9K ﹤0.01% 637

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Cornerstone Advisors (Washington)'s GHDX Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 241 shares — an estimated $14K sold.

Cornerstone Advisors (Washington) first reported a position in GHDX in Q1 2019 and held it in 2 quarters. The position peaked at $17K in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 241 Genomic Health, Inc. shares in Q3 2019, an estimated $14K.
  • Cornerstone Advisors (Washington) first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 2 quarters.
  • Cornerstone Advisors (Washington)'s Genomic Health, Inc. position peaked at $17K in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.